AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05064228 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mobile Rewarding Activity Centered Treatment (m-ReACT)
Description: Participants will utilize m-ReACT for 12-weeks, reporting daily on substance-free activity engagement and enjoyment (EMA). m-ReACT will utilize these EMA reports to generate brief, automated, and personalized feedback about enjoyed categories of substance-free activities as well as make suggestions for increasing engagement in those rewarding, goal-oriented substance-free activities, and provide personalized suggestions of activities of interest.
Study NCT05064228 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile Rewarding Activity Centered Treatment (m-ReACT)
Description: Participants will utilize m-ReACT for 12-weeks, reporting daily on substance-free activity engagement and enjoyment (EMA). m-ReACT will utilize these EMA reports to generate brief, automated, and personalized feedback about enjoyed categories of substance-free activities as well as make suggestions for increasing engagement in those rewarding, goal-oriented substance-free activities, and provide personalized suggestions of activities of interest.
Study NCT06295302 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HWH486
Description: HWH486 capsule was administrated orally
Study NCT06295302 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo was administrated orally
Study NCT05374733 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Coronary Physiology assessment
Description: 1. Pd/Pa, diastolic pressure ratio (dPR), resting full cycle ratio (RFR), FFR, coronary flow reserve (CFR), and index of microvascular resistance (IMR) measurements in the coronary of interest before the valvular intervention.~2. Pd/Pa, dPR, RFR, FFR, vFFR, CFR and IMR measurements in the coronary of interest after the valvular intervention.
Study NCT05610852 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transvesical Single Port Robotic Partial Prostatectomy
Description: A foley catheter is inserted on the sterile field. A suprapubic midline incision is made and the da Vinci SP surgical system is docked percutaneously directly to the bladder. Prior to the operation, a radiologist identifies and segments tumors and the urethra. A transrectal ultrasound probe is inserted and secured into a fixed position. The Koelis software is utilized to fuse MRI and ultrasound images to identify the target lesion in real-time, allowing for intraoperative guidance. The ultrasound probe rotates automatically, allowing for localization of the tumor intraoperatively. Then depending on the area of the tumor, a Hemi or quadrant resection is completed while preserving the nerves, vas deferens, and seminal vesicles. The urethrovesical anastomosis is then performed.
Study NCT05610852 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: High-intensity focused ultrasound (HIFU)
Description: Three contoured measurements are required for the MR fusion system to reproduce the volume of the prostate. Following this, the area to be targeted will be selected in graded fashion from the anterior to posterior of the prostate. Once planning of ROI (region of interest) is complete, the HIFU treatment may begin. Quadrant or hemi ablation will be performed based on the size and complexity of the tumor. The distal margin of the ablation will be kept at least 4 mm away from the external sphincter. The rectal temperature and its distance from the probe will be carefully monitored throughout the procedure.
Study NCT04465396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teduglutide
Description: Participants received 3 mg or 4 mg of Teduglutide SC syringe injection followed by pen injector or vice versa depending upon the treatment sequence AB or BA on Day 1 of Treatment Periods 1 and 2.
Study NCT04465396 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Syringe Injection
Description: Teduglutide was administered using syringe.
Study NCT04465396 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pen injector
Description: Teduglutide was administered using pen injector.
Study NCT06082648 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial magnetic stimulation
Description: The magnetic stimulator equipment is provided by the MagProX100 magnetic stimulator ( MagVenture, Lucernemarken, DK-3520 Farum, Denmark), with 8-shaped coil, a maximum stimulation frequency of 30Hz and a maximum stimulation intensity of 6 Tesla.Stimulation group: Intermittentpulse transcranial magnetic stimulation (iTBS) will be performed with : the cluster consists of 3 pulses, the intra-cluster frequency is 50Hz, the intercluster frequency is 5Hz, the interval is 8.2s for every stimulus. There are 20 cycles and a total of 600 pulses. Each intervention time is 3min11s, and the stimulation intensity is set as 80% resting state motion threshold. The intervention will be performed once a day for 2 weeks.
Study NCT06082648 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Transcranial magnetic stimulationt
Description: The magnetic stimulator equipment is provided by the MagProX100 magnetic stimulator ( MagVenture, Lucernemarken, DK-3520 Farum, Denmark), with 8-shaped coil, a maximum stimulation frequency of 30Hz and a maximum stimulation intensity of 6 Tesla. Patients on the Sham stimulation group will be interfered with the stimulation coil perpendicular to the skull, so that they will hear the sound of machine without having therapeutic effects. The parameters will be the same as those in the stimulation group.
Study NCT05754866 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transbronchial lung cryobiopsy
Description: Lung tissue was obtained by transbronchial lung cryobiopsy for subsequent pathology and clinical diagnosis.
Study NCT05754866 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transbronchial lung biopsy
Description: Lung tissue was obtained by transbronchial lung biopsy for subsequent pathology and clinical diagnosis.
Study NCT04894682 — intervention group
Intervention type: BIOLOGICAL
Intervention: Vaccine inoculation against SARS-CoV-2
Description: Inoculation with any type of approved vaccines according to the standard or recommended dose
Study NCT05583981 — intervention group
Intervention type: OTHER
Intervention: Interview
Description: Participate in interview
Study NCT05205018 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational interviewing performed remotely through videocalls
Description: Remote motivational interviewing will be performed seven time over 12 months, through videocalls. The first four interventions will be performed within two months and the following three will be performed at five, eight and eleven months from enrollment.
Study NCT05887349 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Neck Stabilization Exercise
Description: 1. Control Group exercise program (Cervical Stabilization exercises group)~The patients in the control group will be given cervical stabilization exercises consisting of 3 levels and increasing difficulty. The exercises will be taught to the patients level by level by the physiotherapist for 6 weeks. The subjects will perform the exercises for a total of 6 weeks. Before each exercise session, stretching exercises will be performed on the subjects.
Study NCT05887349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neck Stabilization Exercise + Rocabado Exercises
Description: 2. Intervention group exercise program (the group to which Robacado exercises will be added in addition to cervical stabilization exercises) The exercises to be applied to the control group for 6 weeks will be given to the intervention group in the same order and at weekly intervals. In addition, individuals in this group will be given Robacado exercises.~Robacado exercises:~1. Resting position for the tongue: The tip of the tongue is placed on the upper palate, just behind the front teeth (resting position for the tongue).~2. When the body is in an upright position, scapular retraction and depression movements are performed without disturbing the position of the cervical region.~3. When the body is in an upright position, at C2-C7 levels, hands are clamped on the neck and cranio-cervical flexion is studied.
Study NCT06556862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalpiciclib
Description: 100 mg/d, po., qd, administered on an empty stomach (fasting should be ensured at least 1 hour before and 1 hour after administration). The drug will be administered in a 28-day cycle, with continuously administration in the first 3 weeks (D1-21), and discontinuation in the fourth week (D22-28).
Study NCT06556862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tucidinostat
Description: 25 mg/BIW, po., q2w. The interval between doses should not be less than 3 days (e.g. Monday and Thursday, Tuesday and Friday, Wednesday and Saturday, etc.), administered 30 minutes after meals
Study NCT04740151 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Best PEEP
Description: In OLV, the investigator will perform a PEEP decremental titration trial, decreasing PEEP from 16 to 4 cmH2O (steps of 2-cmH2O, lasting 1 minute). At the end of every step driving pressure (Pplat-PEEP) will be calculated, and the PEEP corresponding to the lowest driving pressure + 2cmH2O will be set.
Study NCT04740151 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard PEEP
Description: In OLV, a PEEP of 5 cm H2O will be set.
Study NCT05229016 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reflection on health-related experiences
Description: This is a questionnaire that was designed to make the patient reflect on positive or negative health-related experiences.
Study NCT04808544 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dinalbuphine sebacate
Description: Naldebain dissolved in benzyl benzoate and sesame oil (a total volume of 2ml) will be prepared in a 5-ml syringe 30 min before administration. Intramuscular injection into the gluteal muscles will be performed by an anesthesiologist under sonography-guidance.
Study NCT04808544 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo solution
Description: Benzyl benzoate and sesame oil served as placebo solution (a total volume of 2ml) will be prepared in a 5-ml syringe 30 min before administration. Intramuscular injection into the gluteal muscles will be performed by an anesthesiologist under sonography-guidance.
Study NCT06451003 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exposure to clinical decision support system and education
Description: Surgeons will receive education regarding post-discharge venous thromboembolism after cancer surgery. An electronic medical record based decision support tool with be initiated that will identify patients who have undergone major abdominopelvic cancer surgery. The tool will permit use of a risk stratification score and advise guideline concordant post-discharge venous thromboembolism prophylaxis strategies.~Patients will receive dedicated venous thromboembolism education at the time of discharge.
Study NCT04988139 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: individualized educational training
Description: 50 min per session, one session per week, 4 sessions per month, of individualized educational training to preschool children with developmental delays under traditional rehabilitation programs
Study NCT06445296 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High-fat meal containing beef
Description: High-fat meal (eggs cooked in butter, croissant) with 80% ground beef.
Study NCT06445296 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-fat meal containing Beyond Meat
Description: High-fat meal (eggs cooked in butter, croissant) with Beyond Meat Cookout Classic.
Study NCT06353165 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Stannous fluoride toothpaste
Description: product containing 0.45% stannous fluoride
Study NCT06353165 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Colgate Dental Cream
Description: product containing 0.76% sodium monofluorophosphate
Study NCT05981157 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anrotinib plus Tirelizumab
Description: Subjects receive Anrotinib, 10mg, QD and Tirelizumab, 200mg, D1, Q3W. Treatment was continued until confirmed disease progression, death, unacceptable toxicity, withdrawal of consent, or investigator decision.
Study NCT04813159 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Remote Ischaemic Conditioning (RIC)
Description: The RIC protocol will comprise inflation of the automated RIC device to 20 mmHg above systolic blood pressure for 5 minutes and deflation for a further 5 minutes, a cycle which will be completed four times in total. The RIC protocol will be repeated daily for the next 2 days.
Study NCT04813159 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham-control
Description: The sham protocol will comprise low-pressure inflation to 20 mmHg for 5 minutes and deflation for a further 5 minutes, a cycle which will be completed four times in total by a visually identical pneumatic cuff used in the active arm. The sham control protocol will be repeated daily for the next 2 days.
Study NCT04788108 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dydrogesterone
Description: Dydrogesterone tablet
Study NCT04788108 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet
Study NCT06256783 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baozhu Keli
Description: Once enrolled, participants will be administrated Baozhu Keli
Study NCT05138406 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Graded Motor Imagery
Description: The graded motor imaging program will be set to 2 weeks each component. Participants will receive lateralization for the first 2 weeks, motor imagery for 2 weeks, and mirror therapy for 2 weeks. At the same time, standard rehabilitation will be applied for 6 weeks. Treatments will begin 24-48 hours after surgery. Treatments will be applied under the control of a physiotherapist 3 days a week and as home exercise 3 days a week.
Study NCT05138406 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Rehabilitation
Description: Standard rehabilitation consisting of cold therapy, stretching and strengthening exercises will be applied. Treatment will be applied under the control of a physiotherapist 3 days a week and as home exercise 3 days a week.
Study NCT05138406 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Rehabilitation
Description: Standard rehabilitation consisting of cold therapy, stretching and strengthening exercises will be applied. Treatment will be applied under the control of a physiotherapist 3 days a week and as home exercise 3 days a week.
Study NCT05542329 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Monitoring by Tele-Medecine
Description: Monitoring by Tele-Medecine
Study NCT04969042 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pins Medical G122 RS
Description: G122RS model implanted spinal cord stimulation device, which could give closed-loop functional stimulation in the epidural space
Study NCT05509153 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NAC
Description: 1g of clinical grade N-Acetylcysteine capsules, taken orally twice a day
Study NCT05509153 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Coated Placebo capsules, manufactured to match appearance and taste, taken orally twice a day
Study NCT05732844 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intervention group with Enna pelvic ball
Description: The home guideline for placement of the vaginal spheres will be as described in next:~st-2nd week 15 minutes, 1 time a day nd-4th week 30 minutes, 1 time a day 4th-8th week 1 hour, 1 time a day 8th-12th week 2 hours, 1 time a day 12th-16th week 3 hours, 1 time a day
Study NCT05732844 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control group
Description: According to the PERFECT score, a daily home guideline for the performance of PFMT will be requested three times a day, two types of exercises (endurance and strength), and eight repetitions of each.
Study NCT05277688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adjuvant concurrent chemoradiotherapy
Description: concurrent chemotherapy: cisplatin（DDP） weekly, 40mg/m2, begin with radiation Drug: cisplatin（DDP） weekly; Intensity modulated radiotherapy (IMRT) is given five fractions per week at 1.8-2 Gy/fraction/day with total dose summed up to 45-50Gy.
Study NCT05277688 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: radiotherapy
Description: Intensity modulated radiotherapy (IMRT) is given five fractions per week at 1.8-2 Gy/fraction/day with total dose summed up to 45-50Gy.
Study NCT05491694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Toripalimab 240mg
Study NCT05491694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epirubicin
Description: 90mg/m2，IVD，q3w
Study NCT05491694 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High Intensity Focused Ultrasoun
Description: HIFU treatment at lesion site
Study NCT05491694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: 600mg/m2，IVD，q3w
Study NCT05491694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC 5，IVD，q3w
Study NCT05491694 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: 260mg/m2，IVD，q3w
Study NCT05374681 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Medical treatment
Description: Medical treatment alone
Study NCT05374681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medical treatment
Description: Medical treatment alone
Study NCT05374681 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Surgical treatment
Description: Surgical treatment alone
Study NCT05374681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Description: Surgical treatment alone
Study NCT05374681 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: embolization of the MMA
Description: The middle meningeal artery will be catheterized then embolized by cyanoacrylates until the occlusion of the MMA.
Study NCT05463549 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Informative video
Description: An informative instructional film regarding the amniocentesis procedure including answers to frequently asked questions.
Study NCT05628779 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TriClip TTVr system (Abbott Vascular)
Description: Edge-to-edge leaflet approximation for the tricuspid valve
Study NCT05628779 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PASCAL TTVr system (Edwards Lifesciences)
Description: Edge-to-edge leaflet approximation for the tricuspid valve
Study NCT05917028 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter Arterial Micro-Embolization
Description: Participants will undergo TAME with Nexsphere-F.
Study NCT06331741 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Anterior cruciate ligament reconstruction, using graft, augmented with collagen membrane
Description: Wrapping graft (tendon of the long fibular muscle) with collagen membrane before implantation
Study NCT06331741 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Anterior cruciate ligament reconstruction, using graft, not augmented with collagen membrane (control group)
Description: Implantation of the native graft (tendon of the long fibular muscle) without any augmentation method
Study NCT06331741 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Resection arthroplasty of the first metatarsophalangeal joint with the introduction of a collagen membrane into the joint cavity
Description: Arthroplasty with consequent collagen membrane implantation
Study NCT05470764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PERINDOPRES® TRIO, 8 mg perindopril tert-butylamine / 2.5 mg indapamide / 10 mg amlodipine tablets
Description: Oral, generic fixed-dose combination of perindopril tert-butylamine (angiotensin-converting-enzyme inhibitor for the treatment of high blood pressure and heart failure), indapamide (thiazide-like diuretic used in the treatment of hypertension and decompensated heart failure) and amlodipine (calcium channel blocker used to treat high blood pressure and coronary artery disease).
Study NCT05470764 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TRIPLIXAM® 10 mg /2.5 mg/10 mg, 10 mg perindopril arginine / 2.5 mg indapamide / 10 mg amlodipine film-coated tablets
Description: Oral, innovative fixed-dose combination of perindopril arginine (angiotensin-converting-enzyme inhibitor for the treatment of high blood pressure and heart failure), indapamide (thiazide-like diuretic used in the treatment of hypertension and decompensated heart failure) and amlodipine (calcium channel blocker used to treat high blood pressure and coronary artery disease).
Study NCT06198114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multi Sensory Therapy
Description: This group will be treated with activity based training by place different( nuts, screws, bullets, coins, paper clips, coloring ,scissor cutting with different shapes , Simulated feeding (by collecting beans with a spoon and transferring them into a container),transfer light and heavy weight objects into empty box. 5 days in a week
Study NCT06198114 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Therapy
Description: This group will be treated with traditional therapy in which Place toys/objects inside and encourage the student to reach in and pull them out as well as put them back in. Give the student objects that can be put together and pulled apart. Encourage the students to use two hands in an organized manner to manipulate objects (e.g., grasp/release, twist/turn, rotate and examine, open/close, stack, nest).5 days a week for an hour/daily.